Labcorp Presents New Research Demonstrating Clinical Impact of Precision Diagnostics in Guiding Biomarker-targeted Therapies for Patients with Epithelial Ovarian Cancer

By / 18/03/2024

Labcorp, a global leader of innovative and comprehensive laboratory services, presented the results from two studies at the 2024 SGO Annual Meeting on Women’s Cancer.